⌘K

Login Start Free

Home/Filings/4/0001583742-23-000001

4//SEC Filing

Hakim Nasrat A 4

Accession 0001583742-23-000001

CIK 0001053369other

View on SEC.gov Company Profile

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 2:21 PM ET

Size

6.2 KB

Accession

0001583742-23-000001

Insider Transaction Report

Form 4

Period: 2023-12-29

ELITE PHARMACEUTICALS INC /NV/ELTP

DirectorPresident & CEO

Transactions

Award
Common Stock
2023-12-29$0.07/sh+2,223,147$153,397→ 2,223,147 total(indirect: Kristine Hakim)

Holdings

Common Stock
158,017,321
Common Stock
(indirect: By IRA)
2,700,000

Footnotes (1)

[F1]Shares issued in lieu of cash compensation for Pharmacovigilance and Medical Affairs consulting work during 2018-2022.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeother

Related Parties

1

filerCIK 0001583742

Filing Metadata

Form type: 4
Filed: Dec 28, 7:00 PM ET
Accepted: Dec 29, 2:21 PM ET
Size: 6.2 KB

View on SEC.gov